August 17, 2020
Article
Use of an IL-6 inhibitor has the potential to prevent the cytokine storm caused by severe COVID-19 infection.
April 05, 2019
A commentary on β-lactam combination therapy for methicillin-resistant Staphylococcus aureus bacteremia.
Investigating RBX2660 for Recurrent C Difficile Infection
Examining Oral Vancomycin as a First-Line CDI Therapy
The Latest on Monkeypox
Assessing Vancomycin and Metronidazole Susceptibility for CDI